Cognitive side-effects of adjuvant treatments

Breast

Volumn 16, Issue 2 SUPPL., 2007, Pages 166-168

  Burstein, Harold J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

"chemo brain"; Adjuvant chemotherapy; Breast cancer; Cognitive dysfunction

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; AUTACOID; TAMOXIFEN;

ADJUVANT THERAPY; ANXIETY; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BREAST CANCER; CANCER PAIN; CANCER SURVIVAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONCENTRATION LOSS; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; FATIGUE; HUMAN; INCIDENCE; LANGUAGE DISABILITY; MEDICAL RESEARCH; MEMORY DISORDER; MENOPAUSE; MENTAL STRESS; METHODOLOGY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME;

EID: 35648942120     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.07.027     Document Type: Article

References (13)

1. Gross J. Chemotherapy fog is no longer ignored as illusion. New York Times, April 29, 2007. Available at: 〈www.nytimes.com〉; 2007 [accessed 15.05.07].
2. Schagen S.B., van Dam F.S.A.M., Muller M.J., et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85 (1999) 640-650
3. Van Dam F.S., Schagen S.B., Muller M.J., et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90 (1998) 210-218
4. Wieneke M.H.J., and Dienst E.R. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 4 (1995) 61-66
5. Ahles T.A., Saykin A.J., Furstenberg C.T., et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20 (2002) 485-493
6. Mar Fan H.G., Houede-Tchen N., Yi Q.L., et al. Fatigue, menopausal symptoms and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23 (2005) 8025-8032
7. Phillips K.A., and Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst 95 (2003) 190-197
8. Wefel J.S., Lenzi R., Theriault R.L., Davis R.N., and Meyers C.A. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 100 (2004) 2292-2299
9. Wagner L.I., Sweet J.J., Butt J., et al. Trajectory of cognitive impairment during breast cancer treatment: a prospective analysis. J Clin Oncol 24 18S (2006) abstract 8500
10. Castellon S.A., Ganz P.A., Bower J.E., et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26 (2004) 955-969
11. Silverman DHS, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 2006 [Epub ahead of print].
12. Tannock I.F., Ahles T.A., Ganz P.A., and van Dam F.S. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22 (2004) 2233-2239
13. Ahles T.A., and Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7 (2007) 192-201